Permaseal

The cardiac muscle has friable structure and can be split along the plane. As a result, if in a myocardium the cut is made, it begins to come off edge of a section. Transapical approach is used for secure access to an internal part of heart using the kerno-punch for creation of round port of access. After the procedure of fabric are pulled together and sewed in an upper point until this area begins to live and will be filled with cicatricial fabric.

In September, 2016 the Permaseal device which is intended for providing to surgeons access and a possibility of reliable closing of the left ventricle without myocardium ushivaniye in a number of minimum invasive cardiological procedures, including transkateterny prosthetics of the aortal valve, transkateterny prosthetics of the mitralny valve and also an open oval window was provided. The device uses technology of fixing PolyCor which at the same time deploys eight fixers connected with each other by a seam in heart tissue at high speeds, forming an opening for access.

After completion of the procedure when it is required to close an opening for access, the sutural loop is extended, and fixers approach, like thongs for tightening of a purse. In clinical trial for check of the Permaseal device led to reduction of time of the procedure and stay in a hospital, decrease in the undesirable phenomena (including the needs for blood transfusion) and also to decrease to zero frequencies of death rate and a stroke within 12 months.

The Permaseal device and technology of fixing PolyCor are products of the American company Micro Interventional Devices (MID) and were approved by Management of the USA on quality control of foodstuff and medicines (FDA).

"Permaseal is the first in a series of the products intended for replacement of need of an ushivaniye at procedures of treatment of structural heart troubles. We are very glad that this technology is available to our surgeons and their patients in the USA and Europe now — the president and the chief executive officer of MID Michael Whitman said. — In the nearest future PolyCor and MyoLast technologies will be used with the broad range of own kateterny products focused on the unsatisfied needs for recovery of three-leaved and mitralny valves and also for fixing of the mitralny valve. The technology platform of MID allows to perform chreskozhno open surgical procedures".